Trial Design Webinars

  1. Beyond The Database: Reaching Real Patients In Real Communities 5/14/2025

    There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.

  2. The Importance Of Reliable Data To Clinical Trial Activation 5/8/2025

    Find an easier way to identify and enroll eligible patients for your clinical trials with quality data and site selection.

  3. Assessing Diversity In Early-Phase Clinical Trials In A Rapidly Changing Regulatory Environment 5/5/2025

    Learn more about structuring early-phase trials to address population variation and the contributing factors to safe drug administration, both of which are essential to a drug development plan.

  4. Illuminating IHC: From Biomarker To Clinical Trial Assay 5/2/2025

    Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.

  5. Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For Success 5/2/2025

    Advance your understanding of pediatric therapeutics with experts who will help you to navigate the complexities of designing age-specific trials and overcome specimen collection obstacles.

  6. The Difference Between Clinical Trial Auditing And Monitoring 4/28/2025

    While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

  7. Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency 4/25/2025

    Karri Venn, VP site advocacy and mentorship at SCRS, emphasized the importance of sponsors recognizing the structure and capabilities of larger site networks.

  8. Clinical Innovators: Co-Designing With Patients 4/16/2025

    In this thought-provoking conversation with leading voices in the biopharma sector, Hilary Thomas discussed how patient insights can be meaningfully woven into clinical trial design.

  9. Evaluating Adaptive Trials: Do They Align With Your Study's Goals? 4/10/2025

    In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.

  10. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.